Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 0 results

Large-scale testing (Phase 3)Study completedNCT00378690
What this trial is testing

A Phase IIIb Study of Intermittent Versus Continuous Hormone Deprivation Treatment With ELIGARD

Who this might be right for
Prostate Cancer
Astellas Pharma Inc 706
Large-scale testing (Phase 3)Looking for participantsNCT04242017
What this trial is testing

Long-term Better Than Short-term ADT With Salvage RT

Who this might be right for
Prostate Cancer
Universitaire Ziekenhuizen KU Leuven 394
Testing effectiveness (Phase 2)Study completedNCT02649790
What this trial is testing

Study of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer Indications

Who this might be right for
Relapsed/Refractory Multiple Myeloma (RRMM)Metastatic Colorectal Cancer (mCRC)Metastatic Castration-Resistant Prostate Cancer (mCRPC)+3 more
Karyopharm Therapeutics Inc 277
Testing effectiveness (Phase 2)Study completedNCT01304485
What this trial is testing

PET Imaging Characteristics of C11-Acetate in Patients With Recurrent Prostate Carcinoma

Who this might be right for
Prostate Cancer
Phoenix Molecular Imaging 2,000
Testing effectiveness (Phase 2)Study completedNCT01790126
What this trial is testing

The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer

Who this might be right for
Prostate Cancer
Aragon Pharmaceuticals, Inc. 90
Testing effectiveness (Phase 2)Study completedNCT01656304
What this trial is testing

Bevacizumab in Treating Patients With Relapsed Prostate Cancer That Did Not Respond to Hormone Therapy

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+3 more
Barbara Ann Karmanos Cancer Institute 16
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Study completedNCT01681823
What this trial is testing

Effect of Modified Citrus Pectin on PSA Kinetics in Biochemical Relapsed PC With Serial Increases in PSA

Who this might be right for
Prostatic Neoplasms
EcoNugenics 60
Not applicableStudy completedNCT04703543
What this trial is testing

Evaluating the Role of Both PSMA and 64Cu-PET/CT Total Body in Patients With Locally Relapsed Prostate Cancer

Who this might be right for
Prostate Neoplasms
Regina Elena Cancer Institute 50
Not applicableWithdrawnNCT04985357
What this trial is testing

Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs

Who this might be right for
Stage III Breast CancerStage IV Breast CancerStage III Lung Cancer+35 more
Travera Inc
Early research (Phase 1)Study completedNCT00082823
What this trial is testing

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Cancer
Regeneron Pharmaceuticals 25
Not applicableNot Yet RecruitingNCT07132671
What this trial is testing

MRI-guided Brachytherapy and Salvage SBRT Program

Who this might be right for
Prostate Cancer (Post Prostatectomy)
Clinica Universidad de Navarra, Universidad de Navarra 29
Testing effectiveness (Phase 2)Study completedNCT05008900
What this trial is testing

Timing of Post-prostatectomy PSMA Imaging

Who this might be right for
Prostate CancerProstatectomy
University Health Network, Toronto 4